Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression

The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases

(2020) M. Yu. Zakharova et al.   Acta Naturae

The Association between Depression and Type 1 Diabetes Mellitus: Inflammatory Cytokines as Ferrymen in between?

(2019) Kexin Wang et al.   MEDIATORS OF INFLAMMATION

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

(2019) J. Rogado et al.   EUROPEAN JOURNAL OF CANCER

Sintilimab: First Global Approval

(2019) Sheridan M. Hoy   DRUGS

Association of HLA-DRB1 and –DQ alleles and haplotypes with Type 1 Diabetes in Jordanians

(2019) Sawsan I. Khdair et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Programmed cell death-1 (PD-1) inhibitor induced type 1 diabetes mellitus: mini-review

(2018) Katrien Clotman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

(2018) Koichi Sato et al.   LUNG CANCER

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction

(2018) Maikel L. Colli et al.   EBioMedicine

Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility

(2018) Chenyue Qian et al.   Journal of Diabetes Research

Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies

(2017) David J. Byun et al.   Nature Reviews Endocrinology

A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome

(2016) Elizabeth Hansen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events

(2016) Elisa González-Rodríguez et al.   ONCOLOGIST

Low programmed cell death-1 (PD-1) expression in peripheral CD4+T cells in Japanese patients with autoimmune type 1 diabetes

(2015) R. Fujisawa et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Meta-analysis of genetic polymorphisms in programmed cell death 1

(2014) Y.H. Lee et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

HLA Class I and Genetic Susceptibility to Type 1 Diabetes: Results From the Type 1 Diabetes Genetics Consortium

(2010) J. A. Noble et al.   DIABETES